Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.

@article{Veiga2000LowMW,
  title={Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.},
  author={Filipe Veiga and Alexandre Escrib{\'a} and Mar{\'i}a P Maluenda and Montserrat L{\'o}pez Rubio and In{\'e}s Margalet and Alicia Lezana and Juan Manuel Gallego and Jos{\'e} Manuel Ribera},
  journal={Thrombosis and haemostasis},
  year={2000},
  volume={84 4},
  pages={559-64}
}
This study aims to establish the relative effectiveness and safety of low molecular weight heparin in elderly patients with venous thrombosis in order to find an alternative to oral anticoagulant therapy with less bleeding complications in the long-term treatment of deep venous thrombosis (DVT). One hundred consecutive elderly patients (>75 years old) with venographically demonstrated proximal DVT were included in a randomized trial. All patients were treated for ten days with adjusted doses of… CONTINUE READING
20 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Similar Papers

Loading similar papers…